KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

Explore the critical benefits of matched tumor-normal sequencing in reducing biological false positives, enabling accurate somatic variant identification, and enhancing germline analysis Analyze real ...

There is no single genetic blueprint for cancer. Instead, each individual cancer draws on a collection of acquired mutations that endow the cells with a selective advantage and superior immune evasion ...

The research team led by Professor Kwang-Hyun Cho of KAIST Bio and Brain Engineering who recently announce "Cancer Reversion Therapy" brings news about another key discovery!

with a plan that uses a paired tumor-normal sequencing panel in a mainstreaming approach. In the following interview, Ying Liu, MPH, MD, lead of the Inherited Gynecologic Cancer Program ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...